How much dividend does Eisai Co pay?
Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 2.39 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.
Eisai Co Dividend 2024
Eisai Co Dividend
160 JPY
Eisai Co Dividend yield
2.39 %
Ticker
4523.T
ISIN
JP3160400002
WKN
855526
How much dividend does Eisai Co 2024 pay?
According to the latest status from May 2024, Eisai Co paid a total of 160 JPY per share in dividends within the last 12 months. With the current Eisai Co price of 6,689 JPY, this corresponds to a dividend yield of 2.39 %. A dividend is paid 2 times per year.
| 2.39 % Dividend Yield | = |
|
Historical Eisai Co Dividends
A dividend is paid 2 times per year. Last year, the payout months were April and October.
| Paydate | Dividend |
|---|---|
| 4/28/2024 | 80 |
| 10/28/2023 | 80 |
| 4/30/2023 | 80 |
| 10/29/2022 | 80 |
| 4/30/2022 | 80 |
| 10/29/2021 | 80 |
| 4/30/2021 | 80 |
| 10/29/2020 | 80 |
| 4/30/2020 | 80 |
| 10/27/2019 | 80 |
| 4/27/2019 | 80 |
| 10/26/2018 | 70 |
| 4/28/2018 | 80 |
| 10/27/2017 | 70 |
| 4/29/2017 | 80 |
| 10/28/2016 | 70 |
| 4/29/2016 | 80 |
| 10/28/2015 | 70 |
| 4/27/2015 | 80 |
| 10/26/2014 | 70 |
1
2
3
4
Eisai Co Stock Dividend JP3160400002 · 855526
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Eisai Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Eisai Co’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Eisai Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Eisai Co Dividend History
| Date | Eisai Co Dividend |
|---|---|
| 2027e | 160.86 undefined |
| 2026e | 161.13 undefined |
| 2025e | 160.96 undefined |
| 2024e | 160.48 undefined |
| 2023 | 160 undefined |
| 2022 | 160 undefined |
| 2021 | 160 undefined |
| 2020 | 160 undefined |
| 2019 | 160 undefined |
| 2018 | 150 undefined |
| 2017 | 150 undefined |
| 2016 | 150 undefined |
| 2015 | 150 undefined |
| 2014 | 150 undefined |
| 2013 | 150 undefined |
| 2012 | 150 undefined |
| 2011 | 150 undefined |
| 2010 | 150 undefined |
| 2009 | 140 undefined |
| 2008 | 135 undefined |
| 2007 | 130 undefined |
| 2006 | 105 undefined |
| 2005 | 96 undefined |
| 2004 | 39 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 39 JPY | 0 JPY |
| 2005 | 96 JPY | 0 JPY |
| 2006 | 105 JPY | 0 JPY |
| 2007 | 130 JPY | 0 JPY |
| 2008 | 135 JPY | 0 JPY |
| 2009 | 140 JPY | 0 JPY |
| 2010 | 150 JPY | 0 JPY |
| 2011 | 150 JPY | 0 JPY |
| 2012 | 150 JPY | 0 JPY |
| 2013 | 150 JPY | 0 JPY |
| 2014 | 150 JPY | 0 JPY |
| 2015 | 150 JPY | 0 JPY |
| 2016 | 150 JPY | 0 JPY |
| 2017 | 150 JPY | 0 JPY |
| 2018 | 150 JPY | 0 JPY |
| 2019 | 160 JPY | 0 JPY |
| 2020 | 160 JPY | 0 JPY |
| 2021 | 160 JPY | 0 JPY |
| 2022 | 160 JPY | 0 JPY |
| 2023 | 160 JPY | 0 JPY |
| 2024e | 0 JPY | 160.48 JPY |
| 2025e | 0 JPY | 160.96 JPY |
| 2026e | 0 JPY | 161.13 JPY |
| 2027e | 0 JPY | 160.86 JPY |
Is the Eisai Co Dividend Safe?
Eisai Co has been increasing the dividend for 1 years.
Over the past 10 years, Eisai Co has increased it by an annual 0.647 %.
Over a five-year period, the distribution increased by 1.299%.
Analysts expect a Dividend Increase of 0.15% for the current fiscal year.
Dividend Details
Understanding Eisai Co's Dividend Distributions
Eisai Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Eisai Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Eisai Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Eisai Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Eisai Co Aktienanalyse
What does Eisai Co do?
Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Eisai Co Stock
What is the dividend yield of Eisai Co?
The current dividend yield of Eisai Co is 2.39 %.
When does Eisai Co pay dividends?
Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Eisai Co?
Eisai Co paid dividends every year for the past 24 years.
What is the dividend of Eisai Co?
For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 2.41 %.
In which sector is Eisai Co located?
Eisai Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Eisai Co from 6/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
When did Eisai Co pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Eisai Co in the year 2023?
In the year 2023, Eisai Co distributed 160 JPY as dividends.
In which currency does Eisai Co pay out the dividend?
The dividends of Eisai Co are distributed in JPY.
Andere Kennzahlen von Eisai Co
Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
